|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/137 | (2006.01) |
| A61K 31/137 | (2013.01) | ||
| A61P 25/26 | (2006.01) | ||
| A61K 31/165 | (2013.01) | ||
| A61K 31/165 | (2006.01) | ||
| A61P 25/26 | (2018.01) |
| (11) | Number of the document | 3897594 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19899707.4 |
| Date of filing the European patent application | 2019-12-19 | |
| (97) | Date of publication of the European application | 2021-10-27 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/067591 |
| Date | 2019-12-19 |
| (87) | Number | WO 2020/132310 |
| Date | 2020-06-25 |
| (30) | Number | Date | Country code |
| 201862782097 P | 2018-12-19 | US |
| (72) |
SOLT, Ken , US
JOHNSON-AKEJU, Oluwaseun , US
|
| (73) |
The General Hospital Corporation ,
55 Fruit Street, Boston, Massachusetts 02114,
US
|
| (54) | DEXTROAMPHETAMINE AND LISDEXAMFETAMINE TO REVERSE DEXMEDETOMIDINE SEDATION |
| DEXTROAMPHETAMINE AND LISDEXAMFETAMINE TO REVERSE DEXMEDETOMIDINE SEDATION |